Today’s Living on the Spectrum update covers the intersection of federal policy debates, breakthroughs in genetic medicine, and practical strategies for managing the complexities of neurodivergent family life.
Controversy Over Federal Autism Research Priorities
Strategic Plan Absence
The Interagency Autism Coordinating Committee (IACC) recently failed to develop a mandated strategic plan for autism research. The Autistic Self Advocacy Network and the Autism Science Foundation expressed concerns that this omission might lead to a lapse in federal funding. Committee members instead focused the session on policy proposals regarding profound autism, medical comorbidities, and elopement.
Redefining Profound Autism
The committee proposed a definition for "profound autism" that excludes IQ scores. IACC chair Sylvia Fogel stated this reflects practical data limitations. However, critics link this shift to proponents of facilitated communication, a discredited technique. Observers also raised alarms regarding the inclusion of topics with weak evidence, such as certain microbiome theories.
Procedural and Transparency Concerns
Critics described the meeting as disorganized and lacking transparency. While Fogel defended the proceedings as advancing long-overdue family priorities, advocacy organizations reported procedural violations. The shift from research strategy to specific policy advocacy remains a point of contention among federal stakeholders.
New Frontiers in Genetic Medicine for Autism
Targeted Genetic Tools
The 2026 International Society for Autism Research (INSAR) meeting highlighted advances in CRISPR, epigenome editing, and antisense oligonucleotides (ASOs). Researchers are using these tools to address rare variants such as SCN2A, SHANK3, and UBE3A. Clinical trials for Angelman syndrome demonstrate that ASOs can un-silence specific genes, leading to measurable improvements in cognition and speech.
Overcoming Biological Barriers
Scientists are refining delivery systems to transport treatments across the blood-brain barrier. Current research focuses on viral vectors and nanoparticles to ensure therapies reach target brain tissues effectively. The U.S. FDA’s Plausible Mechanism Framework helps accelerate these developments for ultra-rare diseases where large-scale trials are difficult to conduct.
Broader Clinical Implications
Breakthroughs in rare genetic variants may eventually provide pathways to treat the broader autistic community. Scientists suggest that normalizing biological pathways in specific genetic conditions could offer therapeutic insights for individuals with profound autism who have no known genetic cause. This represents a shift toward addressing underlying biology rather than just managing behaviors.
SYNGAP1 Mutations and Intellectual Disability
Protein Function in Brain Plasticity
The SYNGAP1 protein acts as a scaffold for neuronal migration and controls the number of neurotransmitter receptors at excitatory synapses. Research indicates that this protein is essential for brain plasticity. SYNGAP1-related intellectual disability (SRID) accounts for approximately 1 percent of intellectual disability cases, with half of those individuals also having autism.
Experimental Disease Models
Using CRISPR, researchers developed mouse models that mirror specific human mutations. A 50 percent reduction in SYNGAP1 protein leads to hyperactivity, repetitive behaviors, and impaired long-term potentiation. These models validate that decreased protein levels are the primary mechanism driving the seizures and developmental delays seen in SRID.
Precision Medicine Approaches
Potential therapies focus on restoring protein levels through antisense oligonucleotides and mRNA-binding technologies. These precision medicine approaches aim to correct the underlying protein deficiency. Such interventions offer a targeted strategy for managing the motor coordination problems and cognitive challenges associated with the mutation.
Navigating Daily Life in ADHD Households
Managing Executive Function at Home
Chores often trigger emotional meltdowns because children with ADHD struggle with the planning and organization required for complex tasks. Parents can reduce friction by breaking tasks into immediate, single steps and working alongside the child. Prioritizing the completion of the task over the child's attitude allows for a more productive environment.
The Impact of Shared Neurodivergence
In households where both parents and children have ADHD, shared traits create both sympathy and conflict. While parents instinctively understand hyperfixations, they often struggle with sensory overload caused by a child’s hyperactivity. Mutual difficulties with executive function can lead to persistent household organization issues and heightened stress when items are misplaced.
Reducing Stress Through Connection
Frequent positive feedback helps reinforce effort and build confidence in neurodivergent children. Physical connection, such as 20-second hugs, can lower anxiety by releasing oxytocin. This practice helps both parents and children move past conflicts and maintain emotional security during difficult daily routines.
Maintaining Strong Partnerships in High-Support Households
Protective Communication Strategies
Raising children with conditions like ADHD, ODD, or SPD requires clear, face-to-face communication between partners. This prevents children from identifying and manipulating disagreements between parents. Avoiding competitive arguments and staying focused on specific issues helps maintain a united front.
Recharging the Relationship
Couples benefit from intentionally nurturing their bond through activities unrelated to parenting. Setting aside time for hobbies and individual recharge time with friends prevents burnout. Simple bedtime rituals of affection ensure that grace and forgiveness remain part of the relationship despite the daily stressors of navigating behavioral disorders.
Shared Learning Rituals
Engaging in one-on-one rituals and learning together about a child’s specific diagnosis helps parents develop shared strategies. This collaborative approach reduces the burden on a single parent and ensures both partners understand the biological basis of their child’s behavior.
The Legacy of a Neurodivergent Trailblazer
Historical Barriers to Diagnosis
In the 1980s and 1990s, adult ADHD was rarely recognized, leaving many parents to struggle with executive functioning without support. Amanda Diekman recounts her mother’s journey to secure a diagnosis during a time of significant social judgment. This early diagnosis facilitated medication and acceptance for other family members, changing the family’s trajectory.
Creating Acceptance Across Generations
Neurodivergent individuals of previous generations often navigated life without modern support networks. By embracing her own neurodivergence, a mother created a home environment where her children could thrive despite their differences. This historical perspective highlights how early self-advocacy laid the foundation for the modern neurodiversity movement.
Podcast Transcript
Aaron: Hello everyone, and welcome to another episode of our podcast where we sit down to talk through the latest news and research in the world of neurodiversity. I’m Aaron.
Jamie: And I’m Jamie. It’s good to be back with you, Aaron. We have a lot of ground to cover today, from some pretty intense meetings at the federal level to some really hopeful breakthroughs in genetic research.
Aaron: You know, Jamie, I was looking through the notes for today’s episode, and I have to say, that first topic about the Interagency Autism Coordinating Committee—the IACC—left me feeling a little bit uneasy. I saw words like "unhinged" being used to describe their recent meeting. For parents who rely on these organizations to guide federal funding and research strategy, that sounds a bit alarming. What’s actually going on there?
Jamie: It was definitely a departure from the norm. To give a little context, the IACC is a federal body that’s supposed to create a strategic plan for autism research. That plan is a big deal because it helps determine where federal money goes. But in this last meeting, they didn't actually work on that plan. Instead, they moved toward policy proposals on things like profound autism, medical co-morbidities, and wandering, which are all huge issues for families, but some critics feel they’re stepping outside their legal mandate.
Aaron: I noticed there was a lot of talk about how they’re defining "profound autism." They’re suggesting a definition that doesn’t include IQ scores. As a parent, that sounds inclusive on the surface—maybe focusing more on what a person needs rather than a test score—but why is that causing so much friction?
Jamie: It’s a delicate balance. On one hand, the committee chair, Sylvia Fogel, argued that IQ data is often missing or hard to get for people with high support needs. But on the other hand, groups like the Autism Science Foundation are worried that by removing these objective measures, we might lose the precision needed for research. There’s also a deep concern because some members linked this new definition to "facilitated communication," which is a technique that the scientific community has largely discredited. When you combine that with discussions on things like the microbiome, which is still in very early, uncertain stages of research, people get nervous that the committee is drifting away from evidence-based science.
Aaron: That makes sense. It’s like they’re trying to address real-world struggles—like elopement and high support needs—but maybe the process felt a bit rushed or less transparent than people expected. It’s a lot for a family to parse through when they just want to know if the research is going to help their child.
Jamie: Exactly. It reminds us that policy and science don't always move at the same speed, and sometimes the "why" behind these meetings is just as important as the "what."
Aaron: Speaking of the science, let’s pivot to something that felt a bit more grounded in the lab. I was reading about the INSAR meeting and this "new era of genetic medicine." They mentioned things like CRISPR and ASOs. For those of us who aren't biologists, what does this actually look like in practice?
Jamie: It’s actually quite remarkable. We’re moving from just identifying genes to trying to influence how they work. For example, with Angelman syndrome, researchers are using these "antisense oligonucleotides"—or ASOs—to basically "un-silence" a gene that isn’t working properly. They’ve seen progress in things like speech and cognition in clinical trials. It’s not just about "fixing" something; it’s about addressing the underlying biology to help the brain function more effectively.
Aaron: I think a big question for many parents is: "My child has profound autism or high support needs, but we don't have a specific genetic diagnosis like Angelman syndrome. Does this research even apply to us?"
Jamie: That was a major point of discussion at the meeting. The idea is that if we can understand these rare genetic variants—like SCN2A or SHANK3—we might find biological pathways that are common to many autistic people, even those without a known genetic cause. It’s like finding a master key that fits several different locks. The FDA is also making it easier to develop treatments for these ultra-rare conditions, which gives a lot of hope to families who were previously told there weren't many options.
Aaron: It sounds like we’re getting closer to "precision medicine," where instead of a one-size-fits-all approach, we’re looking at the specific biological makeup of the individual. I saw a similar theme in the research on SYNGAP1. It’s a protein, right?
Jamie: Yes, SYNGAP1 is a protein that acts like a scaffold in the brain. It helps manage how the brain changes and adapts, which we call plasticity. Recent studies using mouse models showed that when there’s not enough of this protein, it directly leads to things like hyperactivity and difficulty with learning and memory. This is huge because it validates that restoring the protein levels could be a very specific target for new therapies.
Aaron: It’s fascinating how we’re drilling down to that level. But I have to bring it back to the living room for a second. While researchers are looking at proteins, many families are just trying to get through the day. I was reading about the challenges of households where both the parents and the kids have ADHD. It’s a whole different kind of "plasticity" trying to manage a home like that.
Jamie: It really is. There’s that concept of "instinctive sympathy"—where a parent totally gets why their child is hyperfocused on a Lego set—but then you have the "executive function" collision. If both the parent and the child struggle with planning and organization, chores can become a real battlefield.
Aaron: I loved the advice about allowing kids to complain while they work. It sounds so simple, but I think many of us get caught up in wanting our kids to have a "good attitude" while doing chores. But for a kid with ADHD or sensory issues, the chore itself is taking every ounce of their mental energy. Does it really matter if they’re grumbling as long as the dishwasher gets emptied?
Jamie: Right, it’s about picking your battles. And that point about sensory overload is so real. An ADHD parent might be extra sensitive to noise, and an ADHD child might be naturally very loud. It’s a recipe for a meltdown, not because anyone is doing anything "wrong," but because their nervous systems are clashing. That’s why those "20-second hugs" are so often recommended—it’s a physical way to reset the nervous system for both people.
Aaron: It’s funny how the science of oxytocin and the "20-second hug" connects back to the resilience of the parents. I read a piece recently about a woman whose mother was an ADHD "pioneer" back in the 80s. It really made me think about how much harder it must have been back then, without the community and the information we have now.
Jamie: It’s a good reminder of how far we’ve come. That mother was navigating a world that just saw her as "disorganized" or "late," rather than having a brain that was wired differently. By getting her own diagnosis in the 90s, she paved the way for her children to understand themselves. It really highlights that "neurodiversity" isn't just a new buzzword; it’s a lived experience that families have been navigating for generations, often without a map.
Aaron: It definitely puts our current struggles in perspective. Whether it's a messy house, a confusing federal meeting, or a breakthrough in a lab, we’re all just trying to find better ways to support the people we love.
Jamie: And I think that’s a good place to leave it for today. We’re in a period of transition—there’s some tension in the policy world, but incredible momentum in the science, and a lot of heart in the community.
Aaron: Well said, Jamie. Thank you all for joining us for this conversation. If you’d like to dive deeper into any of the articles or research we discussed today, you can find the summaries and original links on our episode page.
Jamie: We hope this was helpful. Take care of yourselves, and we’ll talk again soon.
Aaron: Goodbye everyone.
References
- ‘Slightly unhinged’ federal autism meeting portends unclear research priorities
- Reporter’s notebook: Highlights from INSAR 2026
- SYNGAP1 findings illuminate links between mutations, intellectual disability
- ‘Slightly unhinged’ federal autism meeting portends unclear research priorities
- Advances in genetic medicine took center stage at INSAR
- Four tips for a happier ADHD household
- A Family Full of ADHD
- An Extreme Child Requires Extreme Parents
- A Tribute to My Mom, an ADHD Trailblazer